A hospital-based rectal swab culture survey to detect vancomycin-resistant enterococci

Utility and application

Brian P. Currie, Silvia Gnass, Michael H. Levi

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objectives: To assess the prevalence of vancomycin-resistant enterococcal rectal colonization in a 750-bed hospital (including assessment of the impact of antibiotic use on prevalence) and to compare this method of surveillance to that of monitoring sterile body fluid cultures. Design: A rectal swab culture survey was conducted on a randomly chosen sample of 131 patients who were stratified by prior antibiotic use. Results: The rectal swab culture survey indicated that a minimum of 6.2% of patients were colonized with vancomycin-resistant enterococcal, whereas monitoring sterile body fluid cultures indicated that 0.4% of patients were infected or colonized with vancomycin-resistant enterococci. Oral vancomycin therapy, parenteral vancomycin therapy, and cephalosporin therapy (cefoxitin, ceftriaxone, and ceftazidime) were associated with significantly increased risk of vancomycin-resistant enterococcal rectal colonization. Conclusions: Periodic rectal swab culture surveys are more sensitive in detecting the prevalence of vancomycin-resistant enterococcal colonization and can provide strategic information to guide infection control activities. Restriction of oral and parenteral vancomycin therapy as well as restriction of cephalosporin therapy (cefoxitin, ceftriaxone, and ceftazidime) may contribute significantly to reducing the prevalence of vancomycin-resistant enterococcal colonization.

Original languageEnglish (US)
Pages (from-to)87-91
Number of pages5
JournalInternational Journal of Infectious Diseases
Volume1
Issue number2
StatePublished - 1996

Fingerprint

Vancomycin
Cefoxitin
Ceftazidime
Ceftriaxone
Body Fluids
Cephalosporins
Anti-Bacterial Agents
Therapeutics
Vancomycin-Resistant Enterococci
Surveys and Questionnaires
Infection Control

Keywords

  • Culture survey
  • Surveillance
  • Vancomycin-resistant enterococci

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

A hospital-based rectal swab culture survey to detect vancomycin-resistant enterococci : Utility and application. / Currie, Brian P.; Gnass, Silvia; Levi, Michael H.

In: International Journal of Infectious Diseases, Vol. 1, No. 2, 1996, p. 87-91.

Research output: Contribution to journalArticle

@article{c44ba7a47e254ddfb2bb06fb50c439ba,
title = "A hospital-based rectal swab culture survey to detect vancomycin-resistant enterococci: Utility and application",
abstract = "Objectives: To assess the prevalence of vancomycin-resistant enterococcal rectal colonization in a 750-bed hospital (including assessment of the impact of antibiotic use on prevalence) and to compare this method of surveillance to that of monitoring sterile body fluid cultures. Design: A rectal swab culture survey was conducted on a randomly chosen sample of 131 patients who were stratified by prior antibiotic use. Results: The rectal swab culture survey indicated that a minimum of 6.2{\%} of patients were colonized with vancomycin-resistant enterococcal, whereas monitoring sterile body fluid cultures indicated that 0.4{\%} of patients were infected or colonized with vancomycin-resistant enterococci. Oral vancomycin therapy, parenteral vancomycin therapy, and cephalosporin therapy (cefoxitin, ceftriaxone, and ceftazidime) were associated with significantly increased risk of vancomycin-resistant enterococcal rectal colonization. Conclusions: Periodic rectal swab culture surveys are more sensitive in detecting the prevalence of vancomycin-resistant enterococcal colonization and can provide strategic information to guide infection control activities. Restriction of oral and parenteral vancomycin therapy as well as restriction of cephalosporin therapy (cefoxitin, ceftriaxone, and ceftazidime) may contribute significantly to reducing the prevalence of vancomycin-resistant enterococcal colonization.",
keywords = "Culture survey, Surveillance, Vancomycin-resistant enterococci",
author = "Currie, {Brian P.} and Silvia Gnass and Levi, {Michael H.}",
year = "1996",
language = "English (US)",
volume = "1",
pages = "87--91",
journal = "International Journal of Infectious Diseases",
issn = "1201-9712",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - A hospital-based rectal swab culture survey to detect vancomycin-resistant enterococci

T2 - Utility and application

AU - Currie, Brian P.

AU - Gnass, Silvia

AU - Levi, Michael H.

PY - 1996

Y1 - 1996

N2 - Objectives: To assess the prevalence of vancomycin-resistant enterococcal rectal colonization in a 750-bed hospital (including assessment of the impact of antibiotic use on prevalence) and to compare this method of surveillance to that of monitoring sterile body fluid cultures. Design: A rectal swab culture survey was conducted on a randomly chosen sample of 131 patients who were stratified by prior antibiotic use. Results: The rectal swab culture survey indicated that a minimum of 6.2% of patients were colonized with vancomycin-resistant enterococcal, whereas monitoring sterile body fluid cultures indicated that 0.4% of patients were infected or colonized with vancomycin-resistant enterococci. Oral vancomycin therapy, parenteral vancomycin therapy, and cephalosporin therapy (cefoxitin, ceftriaxone, and ceftazidime) were associated with significantly increased risk of vancomycin-resistant enterococcal rectal colonization. Conclusions: Periodic rectal swab culture surveys are more sensitive in detecting the prevalence of vancomycin-resistant enterococcal colonization and can provide strategic information to guide infection control activities. Restriction of oral and parenteral vancomycin therapy as well as restriction of cephalosporin therapy (cefoxitin, ceftriaxone, and ceftazidime) may contribute significantly to reducing the prevalence of vancomycin-resistant enterococcal colonization.

AB - Objectives: To assess the prevalence of vancomycin-resistant enterococcal rectal colonization in a 750-bed hospital (including assessment of the impact of antibiotic use on prevalence) and to compare this method of surveillance to that of monitoring sterile body fluid cultures. Design: A rectal swab culture survey was conducted on a randomly chosen sample of 131 patients who were stratified by prior antibiotic use. Results: The rectal swab culture survey indicated that a minimum of 6.2% of patients were colonized with vancomycin-resistant enterococcal, whereas monitoring sterile body fluid cultures indicated that 0.4% of patients were infected or colonized with vancomycin-resistant enterococci. Oral vancomycin therapy, parenteral vancomycin therapy, and cephalosporin therapy (cefoxitin, ceftriaxone, and ceftazidime) were associated with significantly increased risk of vancomycin-resistant enterococcal rectal colonization. Conclusions: Periodic rectal swab culture surveys are more sensitive in detecting the prevalence of vancomycin-resistant enterococcal colonization and can provide strategic information to guide infection control activities. Restriction of oral and parenteral vancomycin therapy as well as restriction of cephalosporin therapy (cefoxitin, ceftriaxone, and ceftazidime) may contribute significantly to reducing the prevalence of vancomycin-resistant enterococcal colonization.

KW - Culture survey

KW - Surveillance

KW - Vancomycin-resistant enterococci

UR - http://www.scopus.com/inward/record.url?scp=0343966898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0343966898&partnerID=8YFLogxK

M3 - Article

VL - 1

SP - 87

EP - 91

JO - International Journal of Infectious Diseases

JF - International Journal of Infectious Diseases

SN - 1201-9712

IS - 2

ER -